ImmunoPET in developmental therapeutics

发育治疗中的免疫PET

• 批准号: nhmrc : 1003085
• 负责人: A/Pr Henri Tochon-Danguy
• 金额: $ 37.04万
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2011
• 资助国家: 澳大利亚
• 起止时间: 2011-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/immunopet-developmental-therapeutics/108893
• 关键词: ImmunoPET; developmental; therapeutics

The Ludwig Institute is adopting a two prong approach in the fight against cancer. Ludwig scientists are developing improved and sensitive scanning methods to aid in the conduct of field trials of new anti-cancer antibodies. In addition, they are also developing new targeted anti-cancer antibodies with improved properties that have the ability to bind to tumours while sparing normal tissues. These drugs can either attack the cancer directly or be used to carry drugs to the target thereby shrinking the tumour.

路德维希研究所正在采取双管齐下的方法来对抗癌症。路德维希大学的科学家们正在开发改进的和敏感的扫描方法，以帮助进行新的抗癌抗体的实地试验。此外，他们还在开发新的靶向抗癌抗体，这些抗体具有改进的特性，能够与肿瘤结合，同时保留正常组织。这些药物可以直接攻击癌症，也可以用于将药物携带到靶点，从而缩小肿瘤。